BIOPHEN Factor VIII (bovine reagent R1)
Description
Chromogenic assay for the measurement of factor VIII activity in human plasma or factor VIII concentrates by automated method or for the factor VIII inhibitor assay. The assay is insensitive to emicizumab (Hemlibra®) present in the sample.
It is indicated for measuring low (hemophilia A) or high (increased thrombotic risk) factor VIII concentrations in human citrated plasma and in factor VIII concentrates as well as for performing a factor VIII inhibitor assay.
Intended use
- Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A)
- Follow-up of FVIII recovery in treated patients (exceptemicizumab)
- Factor VIII inhibitor assay in presence oemicizumab
- Measurement of high FVIII concentrations